Novo Nordisk A/S
Novo All
Bagsvaerd,
2880
Denmark - Map
Phone: 45 44 44 88 88
Fax: 45 44 49 05 55
Website: http://www.novonordisk.com
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark. Key Statistics
| |
| | Pay | Exercised | Mr. Lars Rebien S ,
59
Chief Exec. Officer, Pres and Member of the Sr. Management Board | N/A | N/A | Mr. Jesper Brandgaard MSc,
50
Chief Financial Officer, Exec. VP, Member of the Sr. Management Board, Chairman of Novo Nordisk Engineering A/S and Chairman of Novo Nordisk IT A/S | N/A | N/A | Mr. K Schultz ,
52
Chief Operating Officer, Exec. VP and Member of the Sr. Management Board | N/A | N/A | Dr. Mads Krogsgaard Thomsen Ph.D.,
53
Chief Science Officer, Exec. VP and Member of the Sr. Management Board | N/A | N/A | Ms. Lise Kingo ,
52
Chief of Staffs, Exec. VP of Corp. Relations and Member of the Sr. Management Board | N/A | N/A |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.28(0.17%) May 24, 4:02PM EDT